Metagenomi, Inc. Common Stock
MGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $135 | $386 | $386 | $61 |
| - Cash | $27 | $141 | $184 | $39 |
| + Debt | $46 | $48 | $19 | $49 |
| Enterprise Value | $153 | $294 | $220 | $71 |
| Revenue | $52 | $45 | $17 | $0 |
| % Growth | 16.8% | 160.2% | 6,978.2% | – |
| Gross Profit | $52 | -$50 | $15 | -$0 |
| % Margin | 100% | -110.9% | 89.9% | -59.3% |
| EBITDA | -$83 | -$74 | -$39 | -$21 |
| % Margin | -159.7% | -166% | -227.9% | -8,540.3% |
| Net Income | -$78 | -$68 | -$44 | -$21 |
| % Margin | -149.3% | -152.5% | -253.4% | -8,823.9% |
| EPS Diluted | -2.09 | -1.82 | -1.16 | -3.62 |
| % Growth | -14.8% | -56.9% | 68% | – |
| Operating Cash Flow | -$109 | -$91 | $30 | $24 |
| Capital Expenditures | -$3 | -$10 | -$14 | -$3 |
| Free Cash Flow | -$112 | -$101 | $16 | $21 |